文献速递系统性红斑狼疮

代谢组学分析发现血清L-焦谷氨酸可作为系统性红斑狼疮的潜在诊断生物标志物

Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究采用液相色谱-串联质谱代谢组学平台分析32例SLE患者和25例性别匹配健康对照的血清样本,并在独立验证集(36例SLE和30例HC)中验证潜在标志物。结果显示SLE患者血清多种代谢物水平显著改变,其中L-焦谷氨酸在靶向代谢验证中曲线下面积达0.955,灵敏度97.22%、特异度83.33%( cut-off 61.54 μM),提示其作为SLE诊断生物标志物的潜力。

要点

  • SLE患者血清代谢谱与健康对照存在差异,多种代谢物水平显著改变。
  • L-焦谷氨酸在SLE患者中显著升高,靶向验证AUC达0.955。
  • L-焦谷氨酸诊断SLE的灵敏度97.22%、特异度83.33%(cut-off 61.54 μM)。

核心结论

  • 血清代谢谱在SLE患者与健康对照间存在差异,L-焦谷氨酸升高是SLE潜在的诊断生物标志物。

研究设计与样本

  • 研究基于液相色谱-串联质谱代谢组学平台分析32例SLE患者和25例性别匹配健康对照的血清样本,并在独立验证集(36例SLE和30例HC)中进一步验证潜在标志物。

主要发现

  • SLE患者血清花生四烯酸、鞘磷脂24:1、单酰甘油17:0、溶血磷脂酰乙醇胺18:0、溶血磷脂酰乙醇胺16:0、溶血磷脂酰胆碱20:0、溶血磷脂酰胆碱18:0和腺苷水平显著降低。
  • SLE组单酰甘油20:2和L-焦谷氨酸水平显著升高。
  • L-焦谷氨酸在靶向代谢验证中ROC曲线下面积为0.955,cut-off为61.54 μM时灵敏度97.22%、特异度83.33%。

关键数值与推荐

  • L-焦谷氨酸诊断SLE的AUC为0.955,cut-off为61.54 μM,灵敏度97.22%,特异度83.33%。

临床怎么用

  • L-焦谷氨酸有望作为SLE诊断的血清生物标志物,但需进一步大样本验证后方可用于临床辅助诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The spectrum of clinical manifestations and serological phenomena of SLE is heterogeneous among patients and even changes over time unpredictably in individual patients. For this reason, clinical diagnosis especially in complicated or atypical cases is often difficult or delayed leading to poor prognosis. Despite the medical progress nowadays in the understanding of SLE pathogenesis, disease-specific biomarkers for SLE remain an outstanding challenge. Therefore, we undertook this study to investigate potential biomarkers for SLE diagnosis. METHODS: Serum samples from 32 patients with SLE and 25 gender-matched healthy controls (HCs) were analysed by metabolic profiling based on liquid chromatography-tandem mass spectrometry metabolomics platform. The further validation for the potential biomarker was performed in an independent set consisting of 36 SLE patients and 30 HCs. RESULTS: The metabolite profiles of serum samples allowed differentiation of SLE patients from HCs. The levels of arachidonic acid, sphingomyelin (SM) 24:1, monoacylglycerol (MG) 17:0, lysophosphatidyl ethanolamine (lysoPE) 18:0, lysoPE 16:0, lysophosphatidyl choline (lysoPC) 20:0, lysoPC 18:0 and adenosine were significantly decreased in SLE patients, and the MG 20:2 and L-pyroglutamic acid were significantly increased in SLE group. In addition, L-pyroglutamic acid achieved an area under the receiver-operating characteristic curve of 0.955 with high sensitivity (97.22%) and specificity (83.33%) at the cut-off of 61.54 μM in the further targeted metabolism, indicating diagnostic potential. CONCLUSION: Serum metabolic profiling is differential between SLE patients and HCs and depicts increased L-pyroglutamic acid as a promising bitformatomarker for SLE.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Zhang Q, Li X, Yin X, et al. Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus. Rheumatology (Oxford). 2021. PMID: 32259244. doi:10.1093/rheumatology/keaa126

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。